Mapping genetic factors of cardiovascular disease in Hispanic and Latino populations
Leveraging Hispanic/Latino diversity to map and characterize cardiovascular disease loci
This study is looking at how genes might affect heart disease in Hispanic and Latino communities, with the goal of finding ways to better prevent and treat heart-related health issues like obesity, diabetes, and high blood pressure.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11021070 on NIH RePORTER |
What this research studies
This research investigates the genetic factors contributing to cardiovascular disease (CVD) specifically in Hispanic and Latino populations, who face unique health disparities. By conducting genome-wide association studies (GWAS), the research aims to identify genetic loci associated with CVD risk factors such as obesity, type 2 diabetes, and hypertension. The study will enrich the understanding of how these genetic factors influence health outcomes, ultimately aiming to improve prevention and treatment strategies for CVD in these communities.
Who could benefit from this research
Good fit: Ideal candidates for this research are Hispanic and Latino individuals who are at risk for cardiovascular disease or related conditions.
Not a fit: Patients who do not identify as Hispanic or Latino or those without risk factors for cardiovascular disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better-targeted prevention and treatment strategies for cardiovascular disease in Hispanic and Latino populations.
How similar studies have performed: Previous research has shown success in identifying genetic factors for cardiovascular disease in other populations, but this specific focus on Hispanic and Latino groups is relatively novel.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Graff, Mariaelisa — Univ of North Carolina Chapel Hill
- Study coordinator: Graff, Mariaelisa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.